1-methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities
US8211922B2 · kind B2 · utility
0Cited by
9References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 2010 |
| Grant date | Jul 3, 2012 |
| Priority date | — |
| Expiry date | Jan 6, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to nicotinamide derivatives, and their use in treating lipoprotein abnormalities, alone or in combination with a statin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.